7 months ago
GILD
AnalystsLouis ChenLouis Chen's Stock Forecasts
AnalystsLouis Chen
Analyst Ranking
Bottom 16%
#4464 out of 5294 analysts
Average Return
-14.56%
Win Rate
17%1 out of 6
Risk vs Reward
Poor
Good
Louis Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vaxcyte IncPCVX | +84.51% | $22.60 | $41.70 | 2022-02-24 - 2023-02-24 | Strong Buy |
Louis Chen Analyst Color
Get additional color on Louis Chen's coverage of popular stocks
Louis Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gilead Sciences IncGILD | 2 | Buy | $177.00 | +45.70% | Maintains | 4 months ago |
Theratechnologies IncTHTX | 2 | Strong Buy | $36.00 | N/A | Reiterates | 3 years ago |
Zevra Therapeutics IncZVRA | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | $15.25 | N/A | Downgrades | 4 years ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $55.00 | N/A | Reiterates | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.